Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07293650 · ClinicalTrials.gov registry record · Phase 3

PREcision MEDicine In Achalasia (PREMEDIA)

A Phase 3 study, sponsored by Northwestern University.

Recruiting
Registry status
Phase 3
Development phase
372
Enrollment target

NCT07293650 is a Phase 3 study that is actively recruiting participants, run by Northwestern University. The registered enrollment target is 372 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07293650, a Phase 3 study, is actively recruiting participants, sponsored by Northwestern University.

RECRUITING
Registry status
Phase 3
Development phase
372 participants
Enrollment target

Study Summary

The goal of this clinical trial is to learn if shorter Per-Oral Endoscopic Myotomy (POEM) works as well as a longer POEM in patients with trouble swallowing due to certain conditions. The main question\[s\] it aims to answer \[is/are\]: * Does making a smaller cut in the muscle at the bottom of the esophagus work just as well as making the standard bigger cut in relieving symptoms? * Does making the smaller cut reduce the side effects of the procedure compared to the standard bigger cut? Researchers will compare the symptoms and side effects of making a shorter cut to the symptoms and side effects of a longer cut. Participants will allow researchers to access their standard of care information in their medical record, complete questionnaires at up to 6 times over a 2-year period.

Interventions

  • PROCEDURE Standard Myotomy
  • PROCEDURE Tailored Short Myotomy

Trial Details

FieldValue
Enrollment Target 372 participants
Start Date 2026-04-23
Est. Completion 2030-03-01
Phase Phase 3

Sponsor

Northwestern University

1,209 total trials

What the Registry Record Tells You About NCT07293650

The ClinicalTrials.gov registry entry for NCT07293650 describes a study currently listed as recruiting, categorized as Phase 3. The registered enrollment target is 372 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Standard Myotomy is the first listed.

NCT07293650 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT07293650 about?

NCT07293650 is a clinical study titled "PREcision MEDicine In Achalasia (PREMEDIA)". The goal of this clinical trial is to learn if shorter Per-Oral Endoscopic Myotomy (POEM) works as well as a longer POEM in patients with trouble swallowing due to certain conditions. The main question\[s\] it aims to answer \[is/are\]: * Does making a smaller cut in the muscle at the bottom of the...

What is the current status of trial NCT07293650?

This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 372 participants. The study started on 2026-04-23. Estimated completion is 2030-03-01.

What interventions are being tested in trial NCT07293650?

The interventions under investigation include: Standard Myotomy (PROCEDURE), Tailored Short Myotomy (PROCEDURE).

Who is sponsoring clinical trial NCT07293650?

This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.